Product Details
| Sequence: | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
| |
| Formula: | C194H295N53O58S |
| |
| MW: | 4329.9 |
| |
| CAS: | 131438-79-4 |
| |
| Quantity: | *Sold as net peptide weight. |
| |
| Purity: | ≥95% |
| |
| Appearance: | White to off-white powder. |
| |
| Solubility: | Soluble in 5% acetic acid. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease: H. Sticht, et al.; Eur. J. Biochem.
233, 293 (1995),
Abstract;
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease: J.T. Jarrett, et al.; Biochemistry
32, 4693 (1993),
Abstract;
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides: B.A. Yankner, et al.; Science
250, 279 (1990),
Abstract;
